506373 — Citurgia Biochemicals Balance Sheet
0.000.00%
Basic MaterialsMicro Cap
Annual balance sheet for Citurgia Biochemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.685 | 0.54 | 0.784 | 1.05 | 1.19 |
Net Total Receivables | 0.302 | 0.302 | 0.302 | 0.302 | 0.302 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 82.7 | 82.5 | 82.8 | 83 | 83.2 |
Net Property, Plant And Equipment | 15.2 | 13 | 10.7 | 8.47 | 6.21 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 116 | 114 | 112 | 110 | 108 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 85.6 | 88 | 89.4 | 90.5 | 91.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 169 | 171 | 173 | 176 | 178 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -52.5 | -56.6 | -60.9 | -65.7 | -69.9 |
Total Liabilities & Shareholders' Equity | 116 | 114 | 112 | 110 | 108 |
Total Common Shares Outstanding |